 | • レポートコード：MRC2-11QY04128 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は卵巣嚢腫のグローバル市場について調査・分析したレポートです。種類別（画像、CA-125血液検査、腹腔鏡検査）市場規模、用途別（病院・診療所、医療機関、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別卵巣嚢腫の競争状況、市場シェア ・世界の卵巣嚢腫市場：種類別市場規模 2015年-2020年（画像、CA-125血液検査、腹腔鏡検査） ・世界の卵巣嚢腫市場：種類別市場規模予測 2021年-2026年（画像、CA-125血液検査、腹腔鏡検査） ・世界の卵巣嚢腫市場：用途別市場規模 2015年-2020年（病院・診療所、医療機関、研究機関） ・世界の卵巣嚢腫市場：用途別市場規模予測 2021年-2026年（病院・診療所、医療機関、研究機関） ・北米の卵巣嚢腫市場分析：米国、カナダ ・ヨーロッパの卵巣嚢腫市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの卵巣嚢腫市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の卵巣嚢腫市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの卵巣嚢腫市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Teva Pharmaceutical Industries、Quest Diagnostics、Novartis、General Electric、Merck、Boston Scientific、Medtronic ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they may produce bloating, lower abdominal pain, or lower back pain. The majority of cysts are harmless. If the cyst either breaks open or causes twisting of the ovary, it may cause severe pain. This may result in vomiting or feeling faint.
Most women of reproductive age develop small cysts each month, and large cysts that cause problems occur in about 8% of women before menopause. Ovarian cysts are present in about 16% of women after menopause and if present are more likely to be cancer. Benign ovarian cysts are common in asymptomatic premenarchal girls and found in approximately 68% of ovaries of girls 2–12 years old and in 84% of ovaries of girls 0–2 years old. Most of them are smaller than 9 mm while about 10-20% are larger macrocysts. While the smaller cysts mostly disappear within 6 months the larger ones appear to be more persistent.
Market Analysis and Insights: Global Ovarian Cysts Market
The global Ovarian Cysts market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ovarian Cysts Scope and Market Size
Ovarian Cysts market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ovarian Cysts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Teva Pharmaceutical Industries
Quest Diagnostics
Novartis
General Electric
Merck
Boston Scientific
Medtronic
Market segment by Type, the product can be split into
Imaging
CA-125 Blood Test
Laparoscopy
Market segment by Application, split into
Hospitals & Clinics
Medical Institutes
Research Organization
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ovarian Cysts Revenue
1.4 Market by Type
1.4.1 Global Ovarian Cysts Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Imaging
1.4.3 CA-125 Blood Test
1.4.4 Laparoscopy
1.5 Market by Application
1.5.1 Global Ovarian Cysts Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Medical Institutes
1.5.4 Research Organization
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ovarian Cysts Market Perspective (2015-2026)
2.2 Global Ovarian Cysts Growth Trends by Regions
2.2.1 Ovarian Cysts Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ovarian Cysts Historic Market Share by Regions (2015-2020)
2.2.3 Ovarian Cysts Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ovarian Cysts Market Growth Strategy
2.3.6 Primary Interviews with Key Ovarian Cysts Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cysts Players by Market Size
3.1.1 Global Top Ovarian Cysts Players by Revenue (2015-2020)
3.1.2 Global Ovarian Cysts Revenue Market Share by Players (2015-2020)
3.1.3 Global Ovarian Cysts Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ovarian Cysts Market Concentration Ratio
3.2.1 Global Ovarian Cysts Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ovarian Cysts Revenue in 2019
3.3 Ovarian Cysts Key Players Head office and Area Served
3.4 Key Players Ovarian Cysts Product Solution and Service
3.5 Date of Enter into Ovarian Cysts Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ovarian Cysts Historic Market Size by Type (2015-2020)
4.2 Global Ovarian Cysts Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ovarian Cysts Market Size by Application (2015-2020)
5.2 Global Ovarian Cysts Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ovarian Cysts Market Size (2015-2020)
6.2 Ovarian Cysts Key Players in North America (2019-2020)
6.3 North America Ovarian Cysts Market Size by Type (2015-2020)
6.4 North America Ovarian Cysts Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ovarian Cysts Market Size (2015-2020)
7.2 Ovarian Cysts Key Players in Europe (2019-2020)
7.3 Europe Ovarian Cysts Market Size by Type (2015-2020)
7.4 Europe Ovarian Cysts Market Size by Application (2015-2020)
8 China
8.1 China Ovarian Cysts Market Size (2015-2020)
8.2 Ovarian Cysts Key Players in China (2019-2020)
8.3 China Ovarian Cysts Market Size by Type (2015-2020)
8.4 China Ovarian Cysts Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ovarian Cysts Market Size (2015-2020)
9.2 Ovarian Cysts Key Players in Japan (2019-2020)
9.3 Japan Ovarian Cysts Market Size by Type (2015-2020)
9.4 Japan Ovarian Cysts Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ovarian Cysts Market Size (2015-2020)
10.2 Ovarian Cysts Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ovarian Cysts Market Size by Type (2015-2020)
10.4 Southeast Asia Ovarian Cysts Market Size by Application (2015-2020)
11 India
11.1 India Ovarian Cysts Market Size (2015-2020)
11.2 Ovarian Cysts Key Players in India (2019-2020)
11.3 India Ovarian Cysts Market Size by Type (2015-2020)
11.4 India Ovarian Cysts Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ovarian Cysts Market Size (2015-2020)
12.2 Ovarian Cysts Key Players in Central & South America (2019-2020)
12.3 Central & South America Ovarian Cysts Market Size by Type (2015-2020)
12.4 Central & South America Ovarian Cysts Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Ovarian Cysts Introduction
13.1.4 Pfizer Revenue in Ovarian Cysts Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Teva Pharmaceutical Industries
13.2.1 Teva Pharmaceutical Industries Company Details
13.2.2 Teva Pharmaceutical Industries Business Overview
13.2.3 Teva Pharmaceutical Industries Ovarian Cysts Introduction
13.2.4 Teva Pharmaceutical Industries Revenue in Ovarian Cysts Business (2015-2020)
13.2.5 Teva Pharmaceutical Industries Recent Development
13.3 Quest Diagnostics
13.3.1 Quest Diagnostics Company Details
13.3.2 Quest Diagnostics Business Overview
13.3.3 Quest Diagnostics Ovarian Cysts Introduction
13.3.4 Quest Diagnostics Revenue in Ovarian Cysts Business (2015-2020)
13.3.5 Quest Diagnostics Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Ovarian Cysts Introduction
13.4.4 Novartis Revenue in Ovarian Cysts Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 General Electric
13.5.1 General Electric Company Details
13.5.2 General Electric Business Overview
13.5.3 General Electric Ovarian Cysts Introduction
13.5.4 General Electric Revenue in Ovarian Cysts Business (2015-2020)
13.5.5 General Electric Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Ovarian Cysts Introduction
13.6.4 Merck Revenue in Ovarian Cysts Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Boston Scientific
13.7.1 Boston Scientific Company Details
13.7.2 Boston Scientific Business Overview
13.7.3 Boston Scientific Ovarian Cysts Introduction
13.7.4 Boston Scientific Revenue in Ovarian Cysts Business (2015-2020)
13.7.5 Boston Scientific Recent Development
13.8 Medtronic
13.8.1 Medtronic Company Details
13.8.2 Medtronic Business Overview
13.8.3 Medtronic Ovarian Cysts Introduction
13.8.4 Medtronic Revenue in Ovarian Cysts Business (2015-2020)
13.8.5 Medtronic Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Ovarian Cysts Key Market Segments
Table 2. Key Players Covered: Ranking by Ovarian Cysts Revenue
Table 3. Ranking of Global Top Ovarian Cysts Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ovarian Cysts Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Imaging
Table 6. Key Players of CA-125 Blood Test
Table 7. Key Players of Laparoscopy
Table 8. Global Ovarian Cysts Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Ovarian Cysts Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Ovarian Cysts Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Ovarian Cysts Market Share by Regions (2015-2020)
Table 12. Global Ovarian Cysts Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Ovarian Cysts Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Ovarian Cysts Market Growth Strategy
Table 18. Main Points Interviewed from Key Ovarian Cysts Players
Table 19. Global Ovarian Cysts Revenue by Players (2015-2020) (Million US$)
Table 20. Global Ovarian Cysts Market Share by Players (2015-2020)
Table 21. Global Top Ovarian Cysts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cysts as of 2019)
Table 22. Global Ovarian Cysts by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Ovarian Cysts Product Solution and Service
Table 25. Date of Enter into Ovarian Cysts Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 28. Global Ovarian Cysts Market Size Share by Type (2015-2020)
Table 29. Global Ovarian Cysts Revenue Market Share by Type (2021-2026)
Table 30. Global Ovarian Cysts Market Size Share by Application (2015-2020)
Table 31. Global Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 32. Global Ovarian Cysts Market Size Share by Application (2021-2026)
Table 33. North America Key Players Ovarian Cysts Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Ovarian Cysts Market Share (2019-2020)
Table 35. North America Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 36. North America Ovarian Cysts Market Share by Type (2015-2020)
Table 37. North America Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 38. North America Ovarian Cysts Market Share by Application (2015-2020)
Table 39. Europe Key Players Ovarian Cysts Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Ovarian Cysts Market Share (2019-2020)
Table 41. Europe Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Ovarian Cysts Market Share by Type (2015-2020)
Table 43. Europe Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Ovarian Cysts Market Share by Application (2015-2020)
Table 45. China Key Players Ovarian Cysts Revenue (2019-2020) (Million US$)
Table 46. China Key Players Ovarian Cysts Market Share (2019-2020)
Table 47. China Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 48. China Ovarian Cysts Market Share by Type (2015-2020)
Table 49. China Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 50. China Ovarian Cysts Market Share by Application (2015-2020)
Table 51. Japan Key Players Ovarian Cysts Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Ovarian Cysts Market Share (2019-2020)
Table 53. Japan Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Ovarian Cysts Market Share by Type (2015-2020)
Table 55. Japan Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Ovarian Cysts Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Ovarian Cysts Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Ovarian Cysts Market Share (2019-2020)
Table 59. Southeast Asia Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Ovarian Cysts Market Share by Type (2015-2020)
Table 61. Southeast Asia Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Ovarian Cysts Market Share by Application (2015-2020)
Table 63. India Key Players Ovarian Cysts Revenue (2019-2020) (Million US$)
Table 64. India Key Players Ovarian Cysts Market Share (2019-2020)
Table 65. India Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 66. India Ovarian Cysts Market Share by Type (2015-2020)
Table 67. India Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 68. India Ovarian Cysts Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Ovarian Cysts Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Ovarian Cysts Market Share (2019-2020)
Table 71. Central & South America Ovarian Cysts Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Ovarian Cysts Market Share by Type (2015-2020)
Table 73. Central & South America Ovarian Cysts Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Ovarian Cysts Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Teva Pharmaceutical Industries Company Details
Table 81. Teva Pharmaceutical Industries Business Overview
Table 82. Teva Pharmaceutical Industries Product
Table 83. Teva Pharmaceutical Industries Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 84. Teva Pharmaceutical Industries Recent Development
Table 85. Quest Diagnostics Company Details
Table 86. Quest Diagnostics Business Overview
Table 87. Quest Diagnostics Product
Table 88. Quest Diagnostics Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 89. Quest Diagnostics Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. General Electric Company Details
Table 96. General Electric Business Overview
Table 97. General Electric Product
Table 98. General Electric Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 99. General Electric Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Product
Table 103. Merck Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 104. Merck Recent Development
Table 105. Boston Scientific Company Details
Table 106. Boston Scientific Business Overview
Table 107. Boston Scientific Product
Table 108. Boston Scientific Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 109. Boston Scientific Recent Development
Table 110. Medtronic Business Overview
Table 111. Medtronic Product
Table 112. Medtronic Company Details
Table 113. Medtronic Revenue in Ovarian Cysts Business (2015-2020) (Million US$)
Table 114. Medtronic Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ovarian Cysts Market Share by Type: 2020 VS 2026
Figure 2. Imaging Features
Figure 3. CA-125 Blood Test Features
Figure 4. Laparoscopy Features
Figure 5. Global Ovarian Cysts Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Medical Institutes Case Studies
Figure 8. Research Organization Case Studies
Figure 9. Ovarian Cysts Report Years Considered
Figure 10. Global Ovarian Cysts Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Ovarian Cysts Market Share by Regions: 2020 VS 2026
Figure 12. Global Ovarian Cysts Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Ovarian Cysts Market Share by Players in 2019
Figure 15. Global Top Ovarian Cysts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cysts as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Ovarian Cysts Revenue in 2019
Figure 17. North America Ovarian Cysts Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Ovarian Cysts Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Ovarian Cysts Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Ovarian Cysts Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Ovarian Cysts Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Ovarian Cysts Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Ovarian Cysts Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 卵巣がんの世界市場（～2026年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …
- 多嚢胞性卵巣症候群治療の世界市場（～2026年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…
- 卵巣がん治療薬の世界市場（～2026年） Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products. Market Analysis and Insights: Global…
- 転移性卵巣がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Metastatic Ovarian Cancer Drug Market The global Metastatic Ovarian Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metastatic Ovarian Cancer Drug Scope and Market Size …